<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

World

Could Ozempic actually boost Britain’s labour market?

16 October 2024

12:14 AM

16 October 2024

12:14 AM

Is Ozempic the miracle fix for Britain’s labour market woes? This morning Health Secretary Wes Streeting has announced a £280 million investment into the UK from US pharmaceutical giant Lilly, which will include the first ‘real-world trial’ to give weight-loss jabs to people out of work. The news coincides with the publication of the latest labour market overview by the Office for National Statistics, showing the number of people out of work due to long-term sickness is still at a near-record high: 2.75

Already a subscriber? Log in

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Black Friday sale

Subscribe today and get 10 weeks of The Spectator Australia for just $1

Already a subscriber? Log in

Close